|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.2 EUR | -0.89% |
|
+7.39% | +16.03% |
| 16/05 | MERCK KGAA : DZ Bank gives a Buy rating | ZD |
| 16/05 | MERCK KGAA : Gets a Buy rating from Barclays | ZD |
German drugs and chemicals maker Merck KGaA said on Wednesday it would until 2022 focus on cutting its debt from the takeover of electronic materials company Versum and any acquisitions thereafter would likely be smaller ones.
"We don't rule out large transformative deals as of 2022, yet in view of our strong business portfolio, at present the likelihood is higher that we will complement our businesses through a number of smaller to medium-sized acquisitions after 2022," Chief Executive Stefan Oschmann said in a statement.
(Reporting by Ludwig Burger; Editing by Michelle Adair)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.03% | 7.97TCr | |
| +10.23% | 910.95Cr | |
| -10.76% | 520.93Cr | |
| +51.58% | 483.28Cr | |
| +12.50% | 409.46Cr | |
| -20.70% | 234.82Cr | |
| +12.83% | 231.5Cr | |
| +19.51% | 227.39Cr | |
| -29.65% | 218.71Cr | |
| -0.50% | 164.41Cr |
MERCK KGAA 
